Depyrogenated Sterile Empty Vials Market Expected To Grow At 7.9% CAGR Through 2030: What Businesses Need To Know
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Depyrogenated Sterile Empty Vials Market Forecast: What Value Will The Market Reach By 2030?
The depyrogenated sterile empty vials market has experienced robust expansion over recent years. This market is expected to increase from $3.79 billion in 2025 to $4.09 billion in 2026, at a compound annual growth rate (CAGR) of 7.9%. The growth observed in previous periods is largely due to factors such as increasing volumes of injectable drug production, the expansion of sterile pharmaceutical manufacturing processes, stricter regulatory examination of injectable product safety, the rise of biologics and vaccines, and the preference for borosilicate glass in packaging.
The depyrogenated sterile empty vials market is anticipated to experience robust expansion over the coming years. This market is projected to reach $5.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this growth during the forecast period include the escalating demand for biologics and biosimilars, increased investments in aseptic fill-finish facilities, the broadening scope of contract manufacturing services, a heightened emphasis on contamination control, and the wider uptake of pre-sterilized packaging solutions. Key trends anticipated during the forecast period encompass the increasing integration of high-purity injectable packaging, a surge in demand for ready-to-fill vials, a stronger focus on endotoxin-free packaging standards, the scaling up of automated depyrogenation processes, and an elevated prioritization of regulatory-compliant primary packaging.
Get A Free Sample Report With In-Depth Market Insights:
Depyrogenated Sterile Empty Vials Market Industry Drivers: What’s Behind The Revenue Growth?
The global rise in infectious disease cases is anticipated to drive expansion in the depyrogenated sterile empty vials market. These diseases originate from pathogenic microorganisms, including bacteria, viruses, parasites, and fungi. Depyrogenated sterile vials serve as containers for injectable medications utilized in addressing infectious diseases. Furthermore, these depyrogenated sterile empty vials also find application in gathering laboratory specimens. As an illustration, the Health Security Agency, a UK-based government body, reported in February 2024 that tuberculosis (TB) instances in England experienced a 10.7% rise in 2023 when contrasted with 2022. The total number of cases went up from 4,380 in 2022 to 4,850 in 2023. Consequently, the growing global occurrence of infectious diseases will stimulate the growth of the depyrogenated sterile empty vials market.
Depyrogenated Sterile Empty Vials Market Breakdown By Product Type And Application
The depyrogenated sterile empty vials market covered in this report is segmented –
1) By Product: 2 ML, 5 ML, 10 ML, 20 ML, >20 ML
2) By Packaging: Glass, Plastic
3) By End User: Clinical Labs, Compounding Labs, Pharmaceutical Companies, Contract Manufacturing Organization, Distributors
#Depyrogenated Sterile Empty Vials Market Growth Trends: What’s Shaping The Future Outlook?
Leading firms within the depyrogenated sterile empty vials market are concentrating on creating novel items, including deep-cold freeze vials, to address the increasing need for enhanced safety and dependability in biopharmaceutical storage and transportation. These deep-cold freeze vials represent specialized sterile receptacles engineered for the secure containment of biological substances at exceptionally low temperatures, ranging from –80°C to –150°C. Their function is to safeguard delicate drugs, vaccines, and specimens against degradation, preserve their sterility, and guarantee product stability throughout extended storage and transportation periods. As an example, in January 2024, SCHOTT Pharma AG & Co. KGaA, a specialized glass manufacturer from Germany, introduced EVERIC freeze vials, a new series of vials specifically designed for mRNA and gene-therapy items demanding deep-cold storage and superior container integrity. These EVERIC freeze vials are Type I borosilicate glass containers produced and certified for ultralow temperature applications; they incorporate reinforced glass geometry and precise process controls to minimize breakage during freeze-thaw cycles, are compatible with standard lyophilization and cryogenic transport methods, provide exact dimensional accuracy for automated filling and capping processes, and aim to lower delamination/particulate dangers and enhance drug stability versus traditional vials, rendering them appropriate for vaccines, gene-therapy vectors, and other biologics sensitive to temperature.
Depyrogenated Sterile Empty Vials Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the depyrogenated sterile empty vials market are APG Pharma, Corning Inc., DWK Life Sciences, Nipro PharmaPackaging, Schott AG, Thermo Fisher Scientific, Gerresheimer AG, Stevanato Group, SGD Pharma, Merck KGaA, SiO2 Materials Science, Shandong Pharmaceutical Glass Co. Ltd., West Pharmaceutical Services Inc., Ompi Srl, Pacific Vial Manufacturing Inc., Adelphi Healthcare Packaging Limited, Acme Vial and Glass Company LLC, Amposan S.A., BMT Corporation, Cangzhou Four Stars Glass Co. Ltd., Zhejiang Pharmaceutical-Packaging Co. Ltd.
View The Full Depyrogenated Sterile Empty Vials Market Report:
Depyrogenated Sterile Empty Vials Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the depyrogenated sterile empty vials market in 2025. The regions covered in the depyrogenated sterile empty vials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
